Publication: Cost Effectiveness of Rivaroxaban for Stroke Prevention in Atrial Fibrillation Patients for TTR and CHADS2 Score in Lithuania
| dc.contributor.author | Kockaya, G. | |
| dc.contributor.author | Aidietiene, S. | |
| dc.contributor.author | Ergin, Oguzhan G. | |
| dc.contributor.author | Okcun, S. | |
| dc.contributor.author | Kurnaz, M. | |
| dc.date.accessioned | 2025-12-11T00:22:30Z | |
| dc.date.issued | 2019 | |
| dc.department | Ondokuz Mayıs Üniversitesi | en_US |
| dc.department-temp | [Kockaya, G.] ECONiX, Ankara, Turkey; [Aidietiene, S.] Vilnius Univ, Vilnius, Lithuania; [Ergin, Oguzhan G.] 19 Mayis Univ, Samsun, Turkey; [Okcun, S.; Kurnaz, M.] ECONiX, Istanbul, Turkey | en_US |
| dc.description.woscitationindex | Science Citation Index Expanded - Social Science Citation Index | |
| dc.identifier.endpage | S559 | en_US |
| dc.identifier.issn | 1098-3015 | |
| dc.identifier.issn | 1524-4733 | |
| dc.identifier.scopusquality | Q1 | |
| dc.identifier.startpage | S558 | en_US |
| dc.identifier.uri | https://hdl.handle.net/20.500.12712/36216 | |
| dc.identifier.volume | 22 | en_US |
| dc.identifier.wos | WOS:000503167001100 | |
| dc.identifier.wosquality | Q1 | |
| dc.language.iso | en | en_US |
| dc.publisher | Elsevier Science Inc | en_US |
| dc.relation.ispartof | Value in Health | en_US |
| dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
| dc.rights | info:eu-repo/semantics/closedAccess | en_US |
| dc.title | Cost Effectiveness of Rivaroxaban for Stroke Prevention in Atrial Fibrillation Patients for TTR and CHADS2 Score in Lithuania | en_US |
| dc.type | Conference Object | en_US |
| dspace.entity.type | Publication |
